Güncel Gönderiler: Araştırma Çıktıları | Web Of Science

Toplam kayıt 8594, listelenen: 61-80

    • Evolution of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in turkey: a multicenter retrospective analysis 

      Karadag, FK; Yenerel, MN; Yilmaz, M; Uskudar, H; Ozkocaman, V; Tuglular, TF; Erdem, F; Unal, A; Ayyildiz, O; Ozet, G; Comert, M; Kaya, E; Ayer, M; Salim, O; Guvenc, B; Ozdogu, H; Mehtap, O; Sonmez, M; Guler, N; Hacioglu, S; Aydogdu, I; Bektas, O; Toprak, SK; Kaynar, L; Yagci, M; Aksu, S; Tombak, A; Karakus, V; Yavasoglu, I; Onec, B; Ozcan, MA; Undar, L; Ali, R; Ilhan, O; Saydam, G; Sahin, F (2021)
      Paroxysmal nocturnal hemoglobinuria (PNH) is a rare X-linked genetic disorder. On the contrary to its name, it is a multisystemic disease and various symptoms other than hemoglobinuria could be occurred. It could be life ...

    • Identifying Clinical Characteristics of Hypoparathyroidism in Turkey: HIPOPARATURK-NET Study 

      Degertekin, CK; Yavuz, DG; Pekkolay, Z; Saygili, E; Ugur, K; Koca, AO; Unubol, M; Topaloglu, O; Aydogan, BI; Kutbay, NO; Hekimsoy, Z; Yilmaz, N; Balci, MK; Tanrikulu, S; Unsal, YA; Ersoy, C; Omma, T; Keskin, M; Yalcin, MM; Yetkin, I; Soylu, H; Karakose, M; Yilmaz, M; Karakilic, E; Piskinpasa, H; Batman, A; Akbaba, G; Elbuken, G; Bahadir, CT; Kilinc, F; Bilginer, MC; Iyidir, OT; Canturk, Z; Yilmaz, BA; Sayiner, ZA; Eroglu, M (FEB)
      Hypoparathyroidism is an orphan disease with ill-defined epidemiology that is subject to geographic variability. We conducted this study to assess the demographics, etiologic distribution, treatment patterns and complication ...

    • Epidemiological, Clinical, and Laboratory Features of Children With COVID-19 in Turkey 

      Karbuz, A; Akkoc, G; Demirdag, TB; Ciftdogan, DY; Ozer, A; Cakir, D; Torun, SH; Kepenekli, E; Erat, T; Dalgic, N; Ilbay, S; Karaaslan, A; Erdeniz, EH; Aygun, FD; Bozdemir, SE; Hatipoglu, N; Emiroglu, M; Bal, ZS; Ciftci, E; Bayhan, GI; Aydin, ZGG; Demir, SO; Kilic, O; Hacimustafaoglu, M; Okur, DS; Sen, S; Yahsi, A; Akturk, H; Cetin, B; Sutcu, M; Kara, M; Uygun, H; Kara, TT; Korukluoglu, G; Akgun, O; estundag, G; Mis, MD; Sali, E; Kaba, O; Yakut, N; Kilic, O; Kanik, MK; Cetin, C; Dursun, A; Cicek, M; Kockuzu, E; Sevketoglu, E; Alkan, G; Ozenen, GG; Ince, E; Baydar, Z; Ozkaya, AK; Ovali, HF; Tekeli, S; Celebi, S; Cubukcu, B; Bal, A; Khalilova, F; Kose, M; Hatipoglu, HU; Dalkiran, T; Turgut, M; Altas, AB; Duru, HNS; Aksay, A; Saglam, S; Yanartas, MS; Ergenc, Z; Akin, Y; Kar, YD; Sahin, S; Tuteroz, SK; Bilen, NM; Ozdemir, H; Senoglu, MC; Kucukalioglu, BP; Besli, GE; Kara, Y; Turan, C; Demirtas, BS; Celikyurt, A; Cosgun, Y; Elevli, M; Sahin, A; Oguz, SB; Somer, A; Karadag, B; Demirhan, R; Dagi, HT; Kurugol, Z; Taskin, EC; Sahiner, A; Yesil, E; Keles, YE; Sarikaya, R; Eralp, EE; Ozkinay, F; Konca, HK; Yilmaz, S; Gokdemir, Y; Arga, G; Ozen, S; Coksuer, F; Vatansever, G; Tezer, H; Kara, A (MAY 7)
      Objectives: The aim of this study is to identify the epidemiological, clinical, and laboratory features of coronavirus disease 2019 (COVID-19) in children. Methods: A retrospective study was conducted by pediatric infectious ...

    • Clinical and demographic features of hidradenitis suppurativa: a multicentre study of 1221 patients with an analysis of risk factors associated with disease severity 

      Ozkur, E; Karadag, AS; Ustuner, P; Aksoy, B; Esme, P; Caliskan, E; Akoglu, G; Kalkan, G; Demirseren, DD; Polat, M; Ozden, MG; Kilinc, F; Iyidal, AY; Altunay, IK; Turkmen, M; Ugurer, E; Baysak, S; Karaman, BF; Mammadli, K; Selcuk, LB; Turkoglu, Z; Atci, T; Balci, DD; Adisen, E; Temel, B; Aktan, S; Kacar, N; Gunduz, K; Ertmertcan, AT; Ozdemir, M; Cakiter, AU; Colgecen, E; Ucmak, D; Kelekci, H; Ataseven, A; Durmaz, K; Ozden, HK; Engin, B; Yazici, S; Alpsoy, E (APR)
      Background Hidradenitis suppurativa (HS) is a chronic, relapsing and debilitating inflammatory disease associated with profound morbidity. Aim In this multicentre study, we investigated the demographic and clinical features ...

    • Evaluation of the physical and emotional effects of the COVID-19 pandemic on patients with fibromyalgia and chronic low back pain: A multicenter cross-sectional controlled study 

      Bagcier, F; Kibar, S; Evcik, D; Ketenci, A; Sindel, D; Tur, BS; Uenlue, Z; Tikiz, C; Keskin, D; Alp, A; Ay, S; Yanik, B; Kuelcue, DG; Karakas, M; Nazlikul, FGU; Oktay, KNK; Aksoy, MK; Findikoglu, G; Eser, F; Atici, A; Yurdakul, OV; Kocak, FA; Kurt, EE; Ozkan, Y; Dogan, SK; Sultanoglu, TE; Ordahan, B; Umay, EK; Demirhan, E; Yagci, HC; Balbaloglu, O; Tezel, N; Satis, S; Atar, S; Akaltun, MS
      Objectives: This study aimed to investigate the physical and emotional effects of the coronavirus disease 2019 pandemic in patients with fibromyalgia syndrome (FMS) and chronic low back pain (CLBP) patients.Patients and ...

    • European bio-naive spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and response 

      Christiansen, SN; Ornbjerg, LM; Rasmussen, SH; Loft, AG; Askling, J; Iannone, F; Zavada, J; Michelsen, B; Nissen, M; Onen, F; Santos, MJ; Pombo-Suarez, M; Relas, H; Macfarlane, GJ; Tomsic, M; Codreanu, C; Gudbjornsson, B; Van der Horst-Bruinsma, I; Di Giuseppe, D; Glintborg, B; Gremese, E; Pavelka, K; Kristianslund, EK; Ciurea, A; Akkoc, N; Barcelos, A; Sanchez-Piedra, C; Peltomaa, R; Jones, GT; Rotar, Z; Ionescu, R; Grondal, G; Van de Sande, MGH; Laas, K; Ostergaard, M; Hetland, ML (AUG 30)
      Objectives To investigate time trends in baseline characteristics and retention, remission and response rates in bio-naive axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) patients initiating TNF inhibitor ...

    • What We Learned about COVID-19 So Far? Notes from Underground 

      Akyil, FT; Karadogan, D; Gurkan, CG; Yuksel, A; Arikan, H; Eyuboglu, TS; Emiralioglu, N; Gursoy, TR; Serifoglu, I; Toreyin, ZN; Marim, F; Kara, BY; Ozakinci, H; Develi, E; Cakmakci, S; Kusbeci, TC; Karcioglu, O; Gulhan, PY; Ercelik, M; Er, B; Ataoglu, O; Polat, D; Kaya, I; Onyilmaz, TA; Aydin, A; Kizilirmak, D; Er, AB; Kilinc, M; Gunaydin, FE; Gurz, S; Karaoglanoglu, S; Celik, S; Esendagli, D; Toptay, H; Sertcelik, UO; Akgun, M (MAY)
      The novel coronavirus pandemic poses a major global threat to public health. Our knowledge concerning every aspect of COVID-19 is evolving rapidly, given the increasing data from all over the world. In this narrative review, ...

    • A global respiratory perspective on the COVID-19 pandemic: commentary and action proposals 

      To, T; Viegi, G; Cruz, A; Taborda-Barata, L; Asher, I; Behera, D; Bennoor, K; Boulet, LP; Bousquet, J; Camargos, P; Conceicao, C; Diaz, SG; El-Sony, A; Erhola, M; Gaga, M; Halpin, D; Harding, L; Maghlakelidze, T; Masjedi, MR; Mohammad, Y; Nunes, E; Pigearias, B; Sooronbaev, T; Stelmach, R; Tsiligianni, I; Lan, LTT; Valiulis, A; Wang, C; Williams, S; Yorgancioglu, A (JUL 1)

    • Global initiative for Asthma Strategy 2021: executive summary and rationale for key changes 

      Reddel, HK; Bacharier, LB; Bateman, ED; Brightling, CE; Brusselle, GG; Buhl, R; Cruz, AA; Duijts, L; Drazen, JM; FitzGerald, JM; Fleming, LJ; Inoue, H; Ko, FW; Krishnan, JA; Levy, ML; Lin, JT; Mortimer, K; Pitrez, PM; Sheikh, A; Yorgancioglu, AA; Boulet, LP (JAN 1)
      The Global initiative for Asthma (GINA) Strategy Report provides clinicians with an annually updated evidence-based strategy for asthma management and prevention, which can be adapted for local circumstances (e.g. medication ...

    • Education of Healthcare Personnel Working with Pediatric Patients During COVID-19 Pandemic within the Framework of Infection Control 

      Oygar, PD; Buyukcam, A; Bal, ZS; Dalgic, N; Bozdemir, SE; Karbuz, A; Cetin, BS; Kara, Y; Cetin, C; Hatipoglu, N; Uygun, H; Aygun, FD; Torun, SH; Okur, DS; Ciftdogan, DY; Kara, TT; Yahsi, A; Ozer, A; Demir, SO; Akkoc, G; Turan, C; Sali, E; Sen, S; Erdeniz, EH; Kara, SS; Emiroglu, M; Erat, T; Akturk, H; Gurlevik, SL; Sutcu, M; Aydin, ZGG; Atikan, BY; Yesil, E; Guner, G; Celebi, E; Efe, K; Isancli, DK; Durmus, HS; Tekeli, S; Karaarslan, A; Bulbul, L; Almis, H; Kaba, O; Keles, YE; Yazicioglu, B; Oguz, SB; Ovali, HF; Dogan, HH; Celebi, S; Cakir, D; Karasulu, B; Alkan, G; Yenidogan, I; Gul, D; Kucukalioglu, BP; Avcu, G; Kukul, MG; Bilen, M; Yasar, B; Ustun, T; Kilic, O; Akin, Y; Cebeci, SO; Turgut, M; Yanartas, MS; Sahin, A; Arslanoglu, S; Elevli, M; Oz, SKT; Hatipoglu, H; Erkum, IT; Demirbuga, A; Ozcelik, T; Sari, EE; Akkus, G; Hatipoglu, SS; Dinleyici, EC; Hacimustafaoglu, M; Ozkinay, F; Kurugol, Z; Cengiz, AB; Somer, A; Tezer, H; Kara, A (DEC)
      Objective: In the early stages of any epidemic caused by new emerging pathogens healthcare personnel is subject to a great risk. Pandemic caused by SARS-CoV-2, proved to be no exception. Many healthcare workers died in the ...

    • Global Initiative for Asthma Strategy 2021. Executive Summary and Rationale for Key Changes 

      Reddel, HK; Bacharier, LB; Bateman, ED; Brightling, CE; Brusselle, GG; Buhl, R; Cruz, AA; Duijts, L; Drazen, JM; FitzGerald, JM; Fleming, LJ; Inoue, H; Ko, FW; Krishnan, JA; Levy, ML; Lin, JT; Mortimer, K; Pitrez, PM; Sheikh, A; Yorgancioglu, AA; Boulet, LP (JAN)
      The Global Initiative for Asthma (GINA) Strategy Report provides clinicians with an annually updated evidence-based strategy for asthma management and prevention, which can be adapted for local circumstances (e.g., medication ...

    • Global Initiative for Asthma Strategy 2021 Executive Summary and Rationale for Key Changes 

      Reddel, HK; Bacharier, LB; Bateman, ED; Brightling, CE; Brusselle, GG; Buhl, R; Cruz, AA; Duijts, L; Drazen, JM; FitzGerald, JM; Fleming, LJ; Inoue, H; Ko, FW; Krishnan, JA; Levy, ML; Lin, JT; Mortimer, K; Pitrez, PM; Sheikh, A; Yorgancioglu, AA; Boulet, LP (JAN 1)
      The Global Initiative for Asthma (GINA) Strategy Report provides clinicians with an annually updated evidence-based strategy for asthma management and prevention, which can be adapted for local circumstances (e.g., medication ...

    • SECULAR TRENDS IN BASELINE CHARACTERISTICS, TREATMENT RETENTION AND RESPONSE RATES IN 27189 BIO-NAIVE AXIAL SPONDYLOARTHRITIS PATIENTS INITIATING TNFI - RESULTS FROM THE EUROSPA COLLABORATION 

      Ornbjerg, LM; Christiansen, SN; Rasmussen, SH; Loft, AG; Lindstrom, U; Zavada, J; Iannone, F; Onen, F; Nissen, MJ; Michelsen, B; Santos, MJ; Macfarlane, G; Nordstrom, D; Pombo-Suarez, M; Codreanu, C; Tomsic, M; Van der Horst-Bruinsma, I; Gudbjornsson, B; Askling, J; Glintborg, B; Pavelka, K; Gremese, E; Akkoc, N; Ciurea, A; Kristianslund, E; Barcelos, A; Jones, GT; Hokkanen, AM; Sanchez-Piedra, C; Ionescu, R; Rotar, Z; Van De Sande, MGH; Geirsson, AJ; Ostergaard, M; Hetland, ML (JUN)

    • Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries 

      Stolbrink, M; Chinouya, MJ; Jayasooriya, S; Nightingale, R; Evans-Hill, L; Allan, K; Allen, H; Balen, J; Beacon, T; Bissell, K; Chakaya, J; Chiang, CY; Cohen, M; Devereux, G; El Sony, A; Halpin, DMG; Hurst, JR; Kiprop, C; Lawson, A; Mace, C; Makhanu, A; Makokha, P; Masekela, R; Meme, H; Khoo, EM; Nantanda, R; Pasternak, S; Perrin, C; Reddel, H; Rylance, S; Schweikert, P; Were, C; Williams, S; Winders, T; Yorgancioglu, A; Marks, GB; Mortimer, K (NOV 1)
      BACKGROUND: Access to affordable inhaled medicines for chronic respiratory diseases (CRDs) is severely limited in low-and middle-income countries (LMICs), causing avoidable morbidity and mortality. The Inter-national Union ...

    • Global Initiative for Asthma Strategy 2021 Executive Summary and Rationale for Key Changes 

      Reddel, HK; Bacharier, LB; Bateman, ED; Brightling, CE; Brusselle, GG; Buhl, R; Cruz, AA; Duijts, L; Drazen, JM; FitzGerald, JM; Fleming, LJ; Inoue, H; Ko, FW; Krishnan, JA; Levy, ML; Lin, JT; Mortimer, K; Pitrez, PM; Sheikh, A; Yorgancioglu, AA; Boulet, LP (JAN)
      The Global Initiative for Asthma (GINA) Strategy Report provides clinicians with an annually updated evidence-based strategy for asthma management and prevention, which can be adapted for local circumstances (e.g., medication ...

    • The skills of defibrillation practice and certified life-support training in the healthcare providers in Turkey 

      Derinoz-Guleryuz, O; Uysal-Yazici, M; Udurgucu, M; Karacan, C; Akca, H; Ongun, EA; Ekinci, F; Duman, M; Akca-Caglar, A; Vatansever, G; Bilen, S; Uysalol, M; Akcan-Yildiz, L; Saz, EU; Bal, A; Piskin, E; Sahin, S; Kurt, F; Anil, M; Besli, E; Alakaya, M; Gultekingil, A; Yilmaz, R; Temel-Koksoy, O; Kesici, S; Akcay, N; Cebisli, E; Emeksiz, S; Kilinc, MA; Koker, A; Coban, Y; Erkek, N; Gurlu, R; Eksi-Alp, E; Apa, H (DEC)
      Aim of the study Successful cardiopulmonary resuscitation and early defibrillation are critical in survival after in- or out-of-hospital cardiopulmonary arrest. The scope of this multi-centre study is to (a) assess skills ...

    • COVID-19 pandemic alert: time to focus on lung health-Beijing call to action for lung health promotion 

      Chen, W; Varghese, C; Yorgancioglu, A; Troisi, G; Gaga, M; Cen, A; Sooranbaev, T; To, T; Giovanni, V; Alvaro, C; Innes, A; Digamber, B; Kazi, B; Philippe, BL; Jean, B; Paolo, C; Claudia, C; Gonzales, DS; Asma, E; Marina, E; Mina, G; David, H; Letitia, H; Tamaz, M; Reza, MM; Yousser, M; Elizabete, N; Bernard, P; Talant, S; Rafael, S; Luis, TB; Thin, TLL; Arunas, V; Chen, W; Sian, W; Arzu, Y; Varghese, C (JUN)

    • Atezolizumab combined with chemotherapy in the first-line treatment of extensive-stage small cell lung cancer: a real-life data of the Turkish Oncology Group 

      Gurbuz, M; Kutlu, Y; Akkus, E; Koksoy, EB; Kose, N; Oven, BB; Uluc, BO; Demiray, AG; Erdem, D; Demir, B; Turhal, NS; Uskent, N; Akbas, S; Selcukbiricik, F; Inal, A; Bilici, A; Olmez, OF; Cabuk, D; Unal, C; Hizal, M; Sendur, MAN; Korkmaz, M; Karadurmus, N; Erturk, I; Goksu, SS; Tatli, AM; Guven, DC; Kilickap, S; Paksoy, N; Aydiner, A; Cinkir, HY; Ozkul, O; Ozturk, A; Balli, S; Kemal, Y; Erdogan, AP; Er, O; Yumuk, PF; Demirkazik, A (DEC)
      Purpose Atezolizumab has been shown to be effective and safe in randomized trial in the first-line treatment of extensive-stage small cell lung cancer (SCLC). However, there are limited real-life data on atezolizumab. In ...

    • A multicentre prospective analysis of the incidence of pemphigoid diseases in Turkey 

      Durdu, M; Bozca, BC; Enli, S; Ozgen, ZY; Yayli, S; Aktan, S; Mutlu, D; Erturan, I; Celik, HHA; Melikoglu, M; Pala, E; Urun, YG; Harman, M; Savk, E; Isik, S; Duygulu, S; Imren, IG; Karaman, BF; Erdogan, HK; Kilic, A; Ozcelik, S; Inan, K; Yilmaz, MA; Sanli, HE; Yildizhan, IK; Mulayim, MK; Cicek, D; Demir, B; Guner, RY; Selcuk, LB; Gunduz, K; Daye, M; Borlu, M; Solak, EO; Dizman, D; Gunes, B; Ozkur, E; Polat, M; Eskiocak, AH; Uzun, S (NOV)
      Background: The differentiation between the pemphigoid diseases is essential for treatment and prognosis. In Turkey, data on the incidence of these diseases are insufficient. Our aim in this study is to determine the ...

    • The success of the Cystic Fibrosis Registry of Turkey for improvement of patient care 

      Asfuroglu, P; Eyuboglu, TS; Aslan, AT; Gursoy, TR; Emiralioglu, N; Yalcin, E; Kiper, N; Sen, V; Sen, HS; Altintas, DU; Ozcan, D; Kilinc, AA; Cokugras, H; Baskan, AK; Yazan, H; Erenberk, U; Dogan, G; Unal, G; Yilmaz, AI; Keskin, O; Arik, E; Kucukosmanoglu, E; Irmak, I; Damadoglu, E; Ozturk, GK; Gulen, F; Basaran, AE; Bingol, A; Cekic, S; Sapan, N; Kilic, G; Harmanci, K; Kose, M; Ozdemir, A; Tugcu, GD; Polat, SE; Hangul, M; Ozcan, G; Aydin, ZGG; Yuksel, H; Topal, E; Ozdogan, S; Caltepe, G; Suleyman, A; Can, D; Ekren, PK; Bal, CM; Kilic, M; Cinel, G; Cobanoglu, N; Pekcan, S; Cakir, E; Ozcelik, U; Dogru, D (MAY)
      Background Cystic fibrosis (CF) registries play an essential role in improving disease outcomes of people with CF. This study aimed to evaluate the association of newly established CF registry system in Turkey on follow-up, ...